What’s being discussed to ensure interoperability of different credentialing solutions for authorized trading partners (ATPs)? Is GS1 going to set standards for ATP credentialing solutions? If a solution provider supports DSCSA compliance and customers will aggregate serial numbers, why do users need to do anything else?
These were the Top 3questions from “Authorized Trading Partners: The OCI Solution,” the third and final presentation in the “DSCSA 2023” webinar series we hosted last month. rfxcel Global Executive Advisor Brian Files was hosting that day, and we share his answers below.
We also shared our answers to the top questions from the two other webinars, “The Verification Router Service: Aligning to the Standard” and “ASN to EPCIS: Industry Change, Your Challenge.” There’s a lot of good information there, so be sure to check them out!
Our “DSCSA 2023” webinars were part of our ongoing efforts to keep the pharma industry updated about the DSCSA and help all stakeholders be ready for the full serialization of the U.S. pharma supply chain in November 2023. If you have other questions or want more details about DSCSA 2023, contact us today. You can also watch the webinars and download the presentation slides here.
What’s being discussed to ensure interoperability of different ATP credentialing solutions?
The same industry stakeholders are involved in developing the different solutions, whether it’s the Open Credentialing Initiative (OCI), .MED, or XATP. It’s important to have systems that connect and exchange information. The HDA has been hosting meetings with the three ATP providers to determine how/if interoperability can be achieved. Great progress has been made in a short time but there are still many open issues to be resolved as of mid-July 2021.
Is GS1 going to set standards for ATP credentialing solutions?
GS1 is not setting the standards; however, as part of the HDA effort to ensure interoperability, the teams are keeping GS1 updated on their efforts to ensure any GS1 specifications are updated/clarified as needed. For example, ATP will leverage the VRS messaging standards, which may need to be updated/clarified to include ATP.
If a solution provider supports DSCSA compliance and customers will aggregate serial numbers, why do users need to do anything else?
For DSCSA 2023, the onus is on companies to ensure they’re getting their data in the proper format. Just having a DSCSA solution will not make you compliant. You have to go through your operational protocols and procedures and design your internal systems so they’ll be DSCSA-compliant.
Some companies have been working with solution providers since the early days of the DSCSA rollout, but have yet to optimize how their compliance software works with their internal systems, how they work with their provider, and, critically, how they communicate with their trading partners. Companies need to optimize internally to get the most out of their solutions — and to ensure compliance.
More DSCSA 2023 resources from rfxcel
- DSCSA 2023: Understanding DSCSA Authorized Trading Partners, Part 1
- DSCSA 2023: Understanding DSCSA Authorized Trading Partners, Part 2
- DSCSA 2023: The Future of Pharmaceutical Traceability in the United States
- ATP Credentialing in the rfxcel VRS solution
- Plan for DSCSA Readiness webinar with Herb Wong (March 31, 2021)
- Dispensers and DSCSA 2023 (white paper)